Spot on jeff,
Sales were even worse than the headline suggested given that half came from grants. Even i the company manages to land a decent sized contract I still think they'll need to come back to market before they see any cashflow from those sales. Been a frustrating ride.
- Forums
- ASX - By Stock
- PET
- the dog has eaten the homework again
the dog has eaten the homework again, page-3
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PET (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.60M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
PET (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online